openPR Logo
Press release

Pharmaceutical Facility Management – New Book Released

11-18-2013 06:22 PM CET | Science & Education

Press release from: Business Horizons

Pharmaceutical Facility Management

Pharmaceutical Facility Management

The new 2014 second edition of this bestselling book is bigger, better and takes the reader to the next level. Hardbound 424 pages, ISBN: 9788190646796

The new second edition of this bestselling book is bigger, better and takes the reader to the next level and future ready. While the earlier edition was all about smooth and troublefree working of a pharmaceutical facility, the new second edition strives to achieve excellence and set industry benchmarks for facilities of the future. The pharmaceutical facilities of today must reach out beyond the routine and strive for excellence in all spheres of activity, to enable the company retain its competitive edge in the marketplace. To put the facility manager firmly in control of the entire facility, a new chapter has been created specifically to focus on facility manager and the roles and responsibilities that compose the job description of this position.

Social responsibility towards the planet we inhabit has been recognized as our unfailing duty and ways to sustain the ecosystem are constantly being evolved. Since pharmaceutical manufacturing facilities impose lots of demands on the physical environment in which they exist, innovative companies are always trying to lessen their carbon footprint through various methodologies being evolved. What is today seen as innovation will perhaps become mandatory in the near future and hence a new chapter has been introduced called ‘Sustainable Facilities’ that suggests various means by which a company can reduce its carbon footprint.

The most exciting change however in the new edition is the introduction of a new chapter, ‘Operational Excellence in Pharma Manufacturing’ which focuses on manufacturing efficiency for the first time, focusing on actual shop floor strategies rather than arcane management fuzzy logic formulas. While current efficiency levels in the pharmaceutical industry are examined, avenues for excellence are explored that include continuous processing of pharmaceuticals, automated manufacturing, optimizing batch sizes and cycle times and overall equipment effectiveness (OEE). A company can thus develop its own corporate manufacturing strategy based on the technology level it is willing to upgrade to, market and business demands and the resources required for such project.

All other chapters have been thoroughly overhauled, outdated information removed and current and up-to-date information included to transform the existing chapters to cutting edge contemporary standards.

The author JPS Kohli is a pharmacy graduate from University of Delhi followed by Diploma in Management of Technology Transfer, Patents and Information Systems. He has wide ranging experience in the pharmaceutical industry, having worked in a pharmaceutical engineering company followed by working in a pharmaceutical manufacturing facility as Manager-Projects and Exports. He is a member of Indian Pharmaceutical Association (IPA), International Society of Pharmaceutical Engineers (ISPE), American Association of Pharmaceutical Scientists (AAPS), Pharmaceutical and Healthcare Sciences Society (PHSS) and International Federation of Pharmaceuticals (FIP). He is included in Who’s Who in the field of Science and Engineering. He has travelled extensively and visited/audited the manufacturing plants of many companies. He now heads the firm Business Horizons that specializes in books on pharmaceuticals and herbal medicines with an emphasis on technical and quality aspects.

For details visit www.businesshorizons.com or contact info@businesshorizons.com for further information.

Business Horizons, Pharmaceutical Publishers, are leading publishers of technical books for the pharmaceuticals and herbal medicine industry, being sold in over 80 countries worldwide.

BUSINESS HORIZONS
G-59, Masjid Moth, GK-2, New Delhi 110048, INDIA
Tel: +91 921206 1554
Email: info@businesshorizons.com
Website: www.businesshorizons.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmaceutical Facility Management – New Book Released here

News-ID: 275641 • Views:

More Releases from Business Horizons

PHARMA MANUFACTURING COVID-19 CHALLENGE
PHARMA MANUFACTURING COVID-19 CHALLENGE
New Delhi, 19 June, 2020 - Business Horizons, pharmaceutical publishers, announces the launch of their latest publication titled Pharma Manufacturing Covid-19 Challenge. This is their latest offering in the field of pharmaceutical books, after the highly successful earlier book Pharmaceutical Facility Management. In December 2019, China began noticing a disturbing trend of pneumonia like cases that were fast multiplying in the city of Wuhan, the sprawling capital of central China’s Hubei
Achieving Quality and Compliance Excellence in Pharmaceuticals - New Book Released
Achieving Quality and Compliance Excellence in Pharmaceuticals - New Book Releas …
In todays contemporary pharmaceutical industry, the focus has slowly but surely shifted from the elusive research pipeline and latest blockbuster molecules to current processes, efficiencies and manufacturing systems. A path most often taken by manufacturers today in this direction includes improving their overall quality and compliance efforts. This results in a two-pronged approach of minimizing the litigation cost and concurrently improving the overall quality of the products and efficiencies in

More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the